Press Releases on February 27, 2024 - EIN Presswire - Press Release Distribution Service

Published on February 27, 2024 - 21:05 GMT

Venus Concept Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

TORONTO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has closed its previously announced registered direct offering priced at …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 27, 2024 - 21:05 GMT

The Oncology Institute to Participate at Upcoming Investor Conferences

CERRITOS, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology practices in the country, today announced that Dr. Daniel Virnich, TOI’s Chief Executive Officer, will participate at …

Distribution channels: Culture, Society & Lifestyle ...

Published on February 27, 2024 - 21:05 GMT

Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance

PONTE VEDRA, Fla., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities …

Distribution channels:

Published on February 27, 2024 - 21:05 GMT

QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certification

Venlo, the Netherlands, and Redwood City, California, Feb. 27, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of QIAGEN Biomedical KB-AI, a new generative AI-driven knowledge base designed to propel …

Distribution channels: Media, Advertising & PR, Technology ...

Published on February 27, 2024 - 21:05 GMT

Longeveron Reports Year-End 2023 Results and Provides Corporate Update

Company Announces 2024 Strategic Priorities Focused on Advancement of Lomecel-B™ in Hypoplastic Left Heart Syndrome ELPIS II Phase 2 Trial of Lomecel-B™ in HLHS Continues Enrollment; Completion of Study Enrollment Anticipated in 2024 Long-term Survival …

Distribution channels: Business & Economy, Technology ...

Published on February 27, 2024 - 21:05 GMT

Neue KI-gestützte biomedizinische Wissensdatenbank: QIAGEN beschleunigt datenbasierte Arzneimittelforschung

QIAGEN Biomedical KB-AI enthält mehr als 640 Millionen biomedizinische Beziehungen, darunter Kausalzusammenhänge zwischen Genen, Krankheiten und Medikamenten, zur Beschleunigung der datenbasierten Arzneimittelforschung // Ergänzt von Menschen kuratierte …

Distribution channels: Media, Advertising & PR, Technology ...

Published on February 27, 2024 - 21:05 GMT

Jamf Announces Fourth Quarter and Fiscal Year 2023 Financial Results

Q4 total revenue year-over-year growth of 16% to $150.6 million; fiscal year total revenue growth of 17% to $560.6 million ARR year-over-year growth of 15% to $588.6 million as of December 31, 2023 GAAP operating loss of $115.2 million, or (21)% of total …

Distribution channels:

Published on February 27, 2024 - 21:05 GMT

ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023

PORTLAND, Maine, Feb. 27, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …

Distribution channels:

Published on February 27, 2024 - 21:05 GMT

Kronos Bio Announces Participation in 44th Annual Cowen Health Care Conference

SAN MATEO, Calif. and CAMBRIDGE, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today announced participation in the 44th Annual Cowen Health Care …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on February 27, 2024 - 21:05 GMT

Ambarella, Inc. Announces Fourth Quarter and Fiscal Year 2024 Financial Results

SANTA CLARA, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Ambarella, Inc. (NASDAQ: AMBA), an edge AI semiconductor company, today announced fourth quarter and full year fiscal 2024 financial results for the period ended January 31, 2024. Revenue for the …

Distribution channels:

Published on February 27, 2024 - 21:05 GMT

SoundThinking, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

Revenues Increased 24% to a Record $26.0 Million, Marking Highest Quarterly Revenues in Company History Company Introduces FY 2024 Revenue Guidance Range of $104.0 Million to $106.0 Million, Representing 13% Year-Over-Year Growth at the Midpoint and FY …

Distribution channels:

Published on February 27, 2024 - 21:05 GMT

Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences

FOSTER CITY, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on February 27, 2024 - 21:05 GMT

URBN Reports Record Q4 Sales and Strong Earnings Growth

PHILADELPHIA, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Urban Outfitters, Inc. (NASDAQ:URBN), a leading lifestyle products and services company which operates a portfolio of global consumer brands including the Anthropologie, Free People, FP Movement, Urban …

Distribution channels: Business & Economy, Textiles & Fabric Industry ...

Published on February 27, 2024 - 21:05 GMT

Myriad Genetics Reports Strong Fourth Quarter and Full-Year 2023 Financial Results; Fourth Quarter Revenue of $197 Million and ...

Highlights: Full-year testing volume grew 35% year-over-year, or 18% ex-SneakPeek® volume. Full-year 2023 revenue of $753 million, grew 11% year-over-year driven by Prenatal (30%, 15% ex-SneakPeek), Prolaris (21%), Pharmacogenomics (9%), and Hereditary …

Distribution channels:

Published on February 27, 2024 - 21:05 GMT

Udemy to Participate in Two March Investor Conferences

SAN FRANCISCO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Udemy (Nasdaq: UDMY), a leading online skills marketplace and learning platform, today announced that Udemy leadership will participate in two March investor conferences, including: Morgan Stanley TMT …

Distribution channels:

Published on February 27, 2024 - 21:05 GMT

Credo Technology Group Holding Ltd Reports Third Quarter of Fiscal Year 2024 Financial Results

SAN JOSE, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Credo Technology Group Holding Ltd (Nasdaq: CRDO), an innovator in providing secure, high-speed connectivity solutions that deliver improved power and cost efficiency as data rates and corresponding …

Distribution channels:

Published on February 27, 2024 - 21:05 GMT

ICU Medical Announces Fourth Quarter 2023 Results and Provides Fiscal Year 2024 Guidance

SAN CLEMENTE, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended December 31, 2023. Fourth …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on February 27, 2024 - 21:05 GMT

Alector Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Data from INVOKE-2, evaluating the most advanced TREM2 candidate in clinical development for early Alzheimer’s disease (AD), expected in Q4 2024; trial enrollment completed in Q3 2023 First participant in the global PROGRESS-AD Phase 2 clinical trial of …

Distribution channels:

Published on February 27, 2024 - 21:05 GMT

Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date February 15, 2024

NEW YORK, Feb. 27, 2024 (GLOBE NEWSWIRE) -- At the end of the settlement date of February 15, 2024, short interest in 3,153 Nasdaq Global MarketSM securities totaled 10,714,388,932 shares compared with 10,558,925,893 shares in 3,159 Global Market issues …

Distribution channels: Banking, Finance & Investment Industry ...

Published on February 27, 2024 - 21:05 GMT

OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results

MIAMI, Feb. 27, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and 12 months ended December 31, 2023. Business highlights from the fourth quarter and subsequent weeks included the …

Distribution channels: